Literature DB >> 6444770

Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance.

H J Deeg, R Storb, L Gerhard-Miller, H M Shulman, P L Weiden, E D Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6444770     DOI： 10.1097/00007890-198003000-00014

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  10 in total

Review 1.  Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity.

Authors:  P A Keown
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

2.  Cyclosporin in the treatment of severe chronic idiopathic uveitis.

Authors:  J de Vries; G S Baarsma; M J Zaal; T N Boen-Tan; A Rothova; H J Buitenhuis; C M Schweitzer; R J de Keizer; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

3.  Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.

Authors:  L H Block; P M Sutter; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-11-02

4.  Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.

Authors: 
Journal:  Blut       Date:  1980-09

5.  Hepatic and renal function in rats receiving immunotherapeutic doses of cyclosporin A.

Authors:  P H Whiting; A W Thomson; I D Cameron; J G Simpson
Journal:  Br J Exp Pathol       Date:  1980-12

6.  Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.

Authors:  A W Thomson; D K Moon; Y Inoue; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

7.  Cyclosporin A: a new advance in transplantation.

Authors:  B D Kahan
Journal:  Tex Heart Inst J       Date:  1982-09

8.  Cyclosporin A: a powerful immunosuppressant.

Authors:  A Laupacis; P A Keown; R A Ulan; N McKenzie; C R Stiller
Journal:  Can Med Assoc J       Date:  1982-05-01       Impact factor: 8.262

Review 9.  Cyclosporine: immunology, toxicity and pharmacology in experimental animals.

Authors:  A W Thomson; P H Whiting; J G Simpson
Journal:  Agents Actions       Date:  1984-10

10.  Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.

Authors:  Z Wang; C L Halbert; D Lee; T Butts; S J Tapscott; R Storb; A D Miller
Journal:  Gene Ther       Date:  2014-02-06       Impact factor: 5.250
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.